Clinical Trial: A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Warm Autoimmune Hemolytic Anemia
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With An Open Label Safety and Dose Confirmation Run-In Period, To Evaluate the Efficacy and Safety of Obexelimab in Patients
Brief Summary:
This study aims to examine the efficacy and safety of obexelimab in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).
Read more